Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-22-000033

Chief Scientific Officer sold 3,416 shares at $3.09 ($10,541)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kishimoto Takashi Kei Chief Scientific Officer 2022-01-05 Sale −3,416 $3.09 $10,541 268,353 D: show line 1 in the form
Open-market sales · 3,416 sh · avg $3.09 · $10,541
Loading xslF345X03/wf-form4_164159029049282.xml…